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Background: To report our experience with small incision lenticule extraction (“SMILE”) for myopia treatment.
Methods: In this prospective clinical study, we evaluated 447 eyes from 224 patients with myopia, with and
without astigmatism. We followed the patients for 6 months after SMILE.
Results: The mean (±standard deviation, SD) spherical equivalent was -6.75 ± 1.65 diopters (D) preoperatively
and -0.21 ± 0.37 D at 6 months postoperatively. Our data showed that 97.9% of eyes were within ±1.0 D and 86.1%
were within ±0.5 D of the intended correction. Furthermore, 79.8% had an uncorrected distance visual acuity (UDVA)
of 0 logMAR or less (20/20 or better in the Snellen equivalent) 6 months after surgery. Additionally, 48.5% remained
unchanged, 41% gained one line of corrected distance visual acuity (CDVA), 7.2% gained two lines of CDVA, 3.3% lost
one line of CDVA, and 0.3% lost two or more lines of CDVA. Age was the only predictor for worsening UDVA at
6 months postoperatively in linear regression analyses (0.07 decrease logMAR per increased 10 years of age; P < 0.05).
No predictor showed an association with error in spherical equivalent refraction at 6 months postoperatively.
Conclusions: SMILE is an effective and safe refractive surgery. Age was the only predictor that influenced visual
outcome, but its effect appeared clinically insignificant. Faster visual recovery is also expected with improved
surgical technique.
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Laser-assisted in situ keratomileusis (LASIK) has be-
come the standard technique for treating refractive
errors for the past decade because its efficacy and re-
fractive stability have been demonstrated. The procedure
enables faster visual rehabilitation so patients can
quickly return to normal activities [1,2]. However, this
procedure has side effects including dry eye [3], ectasia
[4], and traumatically loosened flaps [5]. Recently, small
incision lenticule extraction (SMILE) has been proposed
as an alternative to LASIK that could avoid these poten-
tial side effects [6]. It has been reported that SMILE
resulted in fewer dry-eye symptoms and higher corneal* Correspondence: Sara514@catholic.ac.kr
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unless otherwise stated.sensitivity [7,8]. Additionally, this procedure should be
able to correct higher levels of myopia because of higher
stromal tensile strength after surgery [9].
In the current study, we investigated the efficacy, pre-
dictability, and safety of SMILE and compared our results
with those from previous studies [6,10-14]. Moreover, we
examined predictors that influenced visual outcome as well
as the effects of incision length on visual outcome.Methods
The Institutional Review Board/Ethics Committee of
Yeouido St. Mary’s Hospital approved this study
(SC14RISI0036). It was performed in accordance with
the tenets of the Declaration of Helsinki. Written in-
formed consent for participation in the study was ob-
tained from all participants. Inclusion criteria for the
study were as follows: spherical myopia up to −12.0 D,
myopic astigmatism up to −4.0 D cyl, minimum age of. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Preoperative patient demographics
Parameter Mean ± SD Range
Manifest sphere(D) −6.18 ± 1.67 −10.0 to −2.25
Manifest cyliner(D) −1.14 ± 0.78 −4.0 to 0
Manifest spherical equivalent(D) −6.75 ± 1.65 −10.50 to −2.25
LogMAR UDVA 1.62 ± 0.25 0.5 to 2.0
LogMAR CDVA −0.056 ± 0.05 −0.2 to 0.2
Corneal power (D) 44.25 ± 1.49 39.4 to 48.3
Central corneal thickness (um) 523.31 ± 31.73 450 to 625
CDVA corrected distance visual acuity, D diopters, UDVA uncorrected distance
visual acuity, D diopters, SD standard deviation.
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40 or better (>0.3 logMAR), and minimum calculated
postoperative residual stromal bed of 250 μm. In
addition, patients had no ocular conditions other than my-
opia. From May 2012 to November 2013, 447 eyes from
224 patients with myopia (with and without astigmatism)
who were treated consecutively with SMILE at the Onnuri
Eye Clinic, Jeonju, Korea, fulfilled these criteria. Patients
were followed for 6 months.
Preoperative assessment
Patients underwent preoperative examinations including
autokeratometry, autorefractometry, intraocular pressure
tonometry (CT-80, Topcon Inc., Japan), pupillometry
(Colvard, Oasis Medical, Glendora, CA), corneal tomog-
raphy, corneal thickness measurements (Galilei, Ziemer
Ophthalmic System, Port, Switzerland), measurement of
uncorrected (UDVA) and corrected distance visual acu-
ity (CDVA), measurement of manifest and cycloplegic
clinical refraction, slit lamp evaluation, and fundoscopy.
Surgical procedure
A VisuMax 500-kHz femtosecond laser (Carl Zeiss
Meditec AG, Jena, Germany) was used for SMILE
treatment. The surgery was performed bilaterally and
under topical anesthesia using three drops of 0.8%
oxybuprocain tetrachloride 2–3 min before surgery.
The patient was positioned under the curved contact
glass of a femtosecond laser and was asked to fixate
on a blinking target. Once appropriate centration was
achieved, suction was applied to the contact glass. We
used 500 kHz, cut energy index 180 nJ femtosecond
laser pulsed, and 4.5-μm spot spacing. First, the back
of the intrastromal lenticule was created by photodis-
ruption from the periphery to the center, followed by
creation of the lenticule front from the center to the
periphery and an incision tunnel located at 11 o/c.
The lenticule diameter was 6.5 mm and the cap diameter
was 7.5 mm. The incision length was 2.0 to 2.5 mm. The
intended cap thickness was 100 to 120 μm. After laser
treatment, a thin blunt spatula was inserted through
the incision site to break the remaining tissue bridges
and loosen the stromal lenticule, which was pulled out
using McPherson forceps (GEUDER, GmbH, Heidelberg,
Germany; M. Blum design) and removed. After the re-
moval of the lenticule, the stromal pocket was flushed
with saline. After surgery, all patients received a topical
antibiotic for 5 days and a topical steroid for 2 weeks.
Hyaluronic acid lubricating drops were prescribed for at
least 2 weeks.
Outcome measures
The follow-up appointments occurred 1 day, 1 week,
1 month, 3 months, and 6 months after surgery. At eachvisit, CDVA, UDVA, objected and manifest refractions,
keratometry, intraocular pressure, corneal topography,
and slit lamp examination were performed. Complica-
tions were noted.
Statistical analyses
Statistical analyses were performed using the SPSS soft-
ware (ver. 18; SPSS Inc., Chicago, IL, USA). Graphics
were generated using Microsoft Excel 2007 (Microsoft
Corporation, Redmond, WA, USA). All values are given
as the means ± standard deviation. Statistical analyses for
visual acuity are based on logMAR units. Bivariate cor-
relation analyses and multiple linear regression analyses
were used to evaluate prognostic factors for visual out-
comes. The preoperative patients and surgical-related
parameters included age, gender, eye side (right/left),
corneal curvature, corneal thickness, intraocular pressure,
attempted change in spherical equivalent refraction, and
degree of astigmatism. Pearson’s χ2 analyses were used to
compare success rates of early postoperative period visual
recovery among groups with different incision lengths.




This study included 293 eyes from 147 females (65.5%)
and 154 eyes from 77 males (34.5%). The mean age was
27.05 ± 6.10 years (range, 18–48 years). Table 1 shows
the preoperative patient characteristics. The target re-
fraction was emmetropia (±0.25 D) in all eyes. There
was no significant difference between parameters for the
right and left eyes.
Efficacy
Figure 1 shows the efficacy of the procedure. UDVA was
20/25 or better in 81.2% of patients 1 day after surgery
and 97.6% after 6 months. UDVA was 20/20 or better in
54.4% of patients 1 day after surgery and 79.8% after
6 months. Table 2 shows the patient demographics and
Figure 1 Efficacy of SMILE. Cumulative percentage of eyes
attaining the specified UDVA levels (Snellen equivalent) at 6 months
after surgery.
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1 week after SMILE. We found that 79.3% of patients in
the 2.0-mm group, 79.3% of patients in the 2.2-mm group,
72.2% of patients in the 2.3-mm group, 69.9% of patients
in the 2.4-mm group, and 64.7% of patients in the 2.5 mm
group had a UDVA of 20/20 or better on the first postop-
erative day. Additionally, 84.48% of patients in the 2.0-mm
group, 81.03% of patients in the 2.2-mm group, 77.78% of
patients in the 2.3-mm group, 84.47% of patients in the
2.4-mm group, and 68.54% of patients in the 2.5-mm
group had a UDVA of 20/20 or better 1 week after surgery.
Patients with smaller incisions had a higher percentage of
eyes with 20/20 or better UDVA on the first postoperative
day (P < 0.05, Pearson’s χ2 test). However, there was no sta-
tistically significant difference among the groups at 1 week
after surgery (P > 0.05, Pearson’s χ2 tests).
Predictability of spherical equivalent (SE)
Figure 2 shows the predictability at 6 months postopera-
tively. We found that 86.1% and 97.9% of eyes treatedTable 2 Patient demographics and SMILE results based on inc
Incision length 2.0 mm 2.2 mm
Eyes(n) 58 58
Age 26.33 ± 6.65 28.52 ± 4.57
Pre operative SE −6.95 ± 1.56 −6.59 ± 1.61
Pre operative CDVA −0.068 ± 0.038 −0.060 ± 0.054
% of eyes UDVA
20/20 or better at 1 day 79.31% 79.31%
% of eyes UDVA
20/20 or better at 1 week 84.48% 81.03%
SE = Spherical equivalent.
CDVA = corrected distance visual acuity.
UDVA = uncorrected distance visual acuity.
*p<.05.using SMILE were within ±0.5 D and ±1.0 D, respect-
ively, of the intended refractive target after 6 months.
Figure 3 shows scatterplot and linear regression analyses
of the attempted SE refractive change plotted against the
achieved SE refractive change 6 months after surgery.
Stability and safety
Postoperative SE values were −0.18 ± 0.4 D after
1 week, −0.20 ± 0.39D after 1 month, −0.21 ± 0.38D after
3 months, and −0.21 ± 0.37D after 6 months (Figure 4).
There was no significant myopic regression from 1 week
to 6 months postoperatively (P = 0.355, paired t-test).
Safety is presented in Figure 5. We report that 48.5% of
eyes had an unchanged CDVA, 41% gained one line, and
7.2% of eyes gained two lines. Moreover, 3% lost one line
and 0.3% lost two lines of CDVA. No cases of epithelial
ingrowth, diffuse lamellar keratitis, or keratoectasia were
observed during the follow up period.
Predictors
Table 3 shows results from bivariate correlation analyses
to identify predictors of visual outcome after surgery.
According to the analyses, age was the only factor that
correlated with UDVA 6 months after surgery. Accord-
ing to linear regression analyses, UDVA worsens as age
increases at 6 months after surgery (decrease of 0.07 logMar
per decade of age; P < 0.05). However, there were no pa-
rameters that correlated with UDVA one day after sur-
gery or with refractive error at 6 months after surgery.
Discussion
The present study involved SMILE treatment of moderate-
to-high myopia in 447 eyes from 224 patients and included
a 6 month follow up period. We controlled for surgical
factors (e.g., laser energy setting and treatment zone) to
precisely evaluate the predictability, efficacy, and stability
of SMILE and to determine predictors that influence visual
outcome.ision length
2.3 mm 2.4 mm 2.5 mm p value
72 103 156
26.58 ± 5.21 27.00 ± 6.25 27.03 ± 6.62 0.289
−7.01 ± 1.51 −6.65 ± 1.67 −6.68 ± 1.73 0.666
−0.063 ± 0.059 −0.059 ± 0.056 −0.056 ± 0.051 0.151
72.22% 69.90% 64.74% 0.013*
77.78% 84.47% 68.54% 0.447
Figure 2 Predictability of SMILE. Percentage of eyes within various diopter ranges of the attempted correction at 6 months after SMILE.
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present study were promising and comparable with
other recently published studies [10-12]. Regarding effi-
cacy, 84%, 73%, and 79% of patients were reported to
have 20/25 or better UDVA in various previous studies
[10-12]. According to the recent study of Sekundo et al.
[13], which reported 1-year results, 98% of patients had
20/25 or better UDVA at 12 months, and 94% and 88%
of patients had 20/20 or better at 6 and 12 months,
respectively. In the present study, 97% and 79.8% ofFigure 3 Predictability of SMILE. Scatter plot showing attempted versus
after SMILE.patients had 20/25 or better UDVA and 20/20 or better
respectively at 6 months after surgery. The reason for
the lower percentage of 20/20 or better in this study ver-
sus that of Sekundo et al. [13] is thought to be the larger
number of eyes and higher average degree of myopic
correction versus their study.
For predictability, 80.1%, 77%, 91% and 92% were
within ±0.5 D and 94.2%, 95%, 98% and 100% were
within ±1.0D of the attempted refraction in the various
previous studies [10-13]. In the present study, 86.1% andachieved manifest spherical equivalent (SE) correction at 6 months
Figure 4 Stability of SMILE. Mean SE plotted as a function of postoperative time.
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6-month follow-up.
Regarding safety, Hjortdal et al. [12] reported that
2.4% of eyes lost two or more lines, 15% lost one line,
and 83.1% were the same or improved. Anders et al. [11]
reported that 4.1% of eyes lost one line, whereas 95.9%
were the same or improved after 3 months. In the study
by Shah et al. [10], 4% of eyes lost one line, and 96%
were the same or improved at 6 months. Similarly,
Sekundo et al. [13] reported that 11% of eyes lost one
line, and 89% were the same or improved at 12 months.
In the present study, 0.3% of eyes lost two lines, 3%
lost one line, and 96.7% were the same or improved at
6 months after surgery. Anders et al. [11] reported that
there was a slight but significant regression from 1 week
to 1 month after surgery. Sekundo et al. [13] also re-
ported 0.08 D regression after 12 months. In the present
study, no myopic regression was observed from 1 week
to 6 months. It also needs to be confirmed whether re-
gression will be evident after 12 months of observation.
According to Hjortdal et al. [12], age, corneal power,
gender (female), and eye (left) were predictive factors
that influenced SE correction errors in multiple regressionFigure 5 Safety of SMILE. CDVA gain and loss at 6 months postoperativeanalyses. These authors suggested that increasing age, cor-
neal power, female gender, and right eye affliction influ-
enced the refractive outcome using an undercorrection.
However, in the present study, none of these factors were
predictors that influenced errors in SE correction. For pre-
dictors that influenced UDVA, Hjortdal et al. [12] reported
that increasing age and female gender were risk factors for
worsening UDVA at 3 months after surgery. In the present
study, however, age was the only risk factor for worsening
UDVA at 6 months after surgery (decrease of 0.07 logMar
per decade increase in age). However, the effect was so
small that it appears clinically insignificant. The present
study corroborated the previous predictor analyses of
Hjortdal et al. [12] and suggested that SMILE is predictable
regardless of diverse patient factors such as gender, corneal
power, and amount of correction.
The slight delay in UDVA recovery in the early post-
operative period is a unique characteristic of FLEx and
SMILE [14-16]. Shah et al. [15] and Demirok et al. [16]
reported that initial visual recovery after FLEx was slower
than Femto LASIK despite successful refractive correction.
Interface haze formation is one of the most common ad-
verse events after this procedure that caused delayed visually.
Table 3 Predictors for visual outcome at 6 months postoperatively using bivariate correlation analyses
Covariate (preoperative factors) UCVA at 1 day UCVA at 6 months Refractive error at 6 months
Pearson correlation analysis
r p value r p value r p value
Age 0.077 0.104 0.139 0.044* 0.106 0.496
Central corneal thickness −0.017 0.726 0.058 0.293 −0.026 0.639
Corneal power 0.076 0.108 0.006 0.915 −0.01 0.859
Spherical equivalent −0.035 0.461 −0.162 0.301 0.41 0.081
Astigmatism −0.051 0.282 −0.087 0.113 0.147 0.347
Intraocular pressure −0.007 0.88 0.135 0.514 −0.147 0.237
*p<.05.
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the incidence of interface haze formation was decreased
after using the higher frequency femtosecond laser and
applying lower energy, which reduces irregularity of the
interface surface [17,18]. Others have reported that early
visual recovery was affected by laser trajectory [15]. A fas-
ter visual recovery was noted when the back of lenticule
was scanned from the periphery to the center and the
front of the lenticule scanned from the center to the per-
iphery. Thus, this preferred method has been used in
many studies, including that presented here.
We found that the initial visual recovery was faster
compared with recent studies that also used the newer-
generation femtosecond laser (500 kHz). Although 40%
and 62.3% of patients had UDVA that was 20/25 or better
on the first postoperative day in previous reports11–12,
81.2% of patients had similar UDVA values in the present
study. In particular, 91.4% and 96.6% of patients who
received 2.0 mm incision lengths (n = 58) had UDVA
20/25 or better on the first day and 1 week after surgery,
respectively.
The faster initial visual recovery noted in the present
study may be attributed to the use of different laser set-
tings or to improved surgical factors, such as smaller in-
cision lengths. Laser settings of higher pulse energy and
larger spot spacing appear to aid faster initial visual re-
covery. The laser setting of 180-nJ pulse energy and
4.5-μm spot spacing in the present study showed fas-
ter initial visual recovery compared to the previously
reported 120 to 150-nJ pulse energy and 2.5-μm spot
spacing [11]. Additionally, Hjortdal et al. [12] reported
better visual acuity using 170-nJ pulse energy and 4.5-μm
spot spacing compared to 125-nJ pulse energy and 2.5-μm
spot spacing. Laser settings should be optimized in future
studies to improve the initial visual recovery.
To our knowledge, no reported study has evaluated
the effect of incision length on visual outcome after
SMILE. The present study found that as incision length
decreased, visual recovery on the first postoperative
day was more rapid (P = 0.013). However, there were nosignificant differences among the various incision length
groups after 1 week. The length of incision did not
affect other refractive results, including error in SE and
amount of astigmatism after surgery. However, there
are several weaknesses in the comparisons among inci-
sion groups. Although all eyes were treated by one
surgeon, there was no randomization of the incision
groups and the numbers of eyes differed significantly by
group. Moreover, this analysis of the effects of incision
size was, in fact, retrospective, because we had not
planned to analyze the effects of incision size on visual
outcome when the study was designed. There is also a
possibility that the surgeon may have become more skill-
ful when the smaller incision group was treated com-
pared with when the larger incision group was treated, in
a relatively early period. In our experience, as the surgeon
became adept at smaller incisions, the surgeon could
achieve manipulations more readily, as with a larger inci-
sion, during the SMILE procedure. Thus, it becomes pos-
sible to benefit from the smaller incision, with increased
corneal stability and rapid epithelial healing, which may
aid in more rapid visual recovery. Presently, we cannot
exclude the possibility of better initial visual outcomes
because of the smaller incisions, not only greater surgeon
experience. The relationship between incision length and
HOA after surgery should be evaluated in future studies.
Hjortdal et al. [12] reported that the right eye showed
better UDVA on the first postoperative day compared to
the left eye. However, we did not observe any difference
in UDVA in the left and right eyes 1 day after surgery.
One eye that had undercorrected SE of −1.63 D and
20/40 UDVA after 6 months was retreated in the present
study. The eye had a refraction of emmetropia (−0.25 D)
and 20/20 UDVA with no other complication 3 months
after the surface ablation procedure (PRK).
Conclusions
The present study had a large number of samples, rela-
tively long-term observation, and treated moderate-
to-severe myopia. Our data indicate that SMILE is an
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http://www.biomedcentral.com/1471-2415/14/117effective and safe refractive surgery. Moreover, by devel-
oping laser platforms and improving surgical techniques,
it is anticipated that the slow visual recovery that is con-
sidered a drawback of SMILE can be improved. This pro-
cedure would likely be preferred by patients who desire
safer refractive surgery with faster visual recovery.
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